<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">454</article-id>
<article-id pub-id-type="doi">10.54660/IJMBHR.2026.7.1.181-187</article-id>
<title-group><article-title>Pterygium Excision with Conjunctival Flap Transposition and Intraoperative Mitomycin C Adjunctive Therapy</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Pawar</surname><given-names>Hrushikesh</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Dubey</surname><given-names>Priyanka</given-names></name><xref ref-type="aff" rid="aff2"/></contrib>
<contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Anshu</given-names></name><xref ref-type="aff" rid="aff3"/></contrib>
<contrib contrib-type="author"><name><surname>Pawaiya</surname><given-names>Shikha</given-names></name><xref ref-type="aff" rid="aff4"/></contrib>
<contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Ankit</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Srivastava</surname><given-names>Mohit</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<aff id="aff1"><label>1</label>PG Junior Resident, Department of Ophthalmology, Rama Medical College Hospital and Research Centre, Hapur, Uttar Pradesh, India</aff>
<aff id="aff2"><label>2</label>Associate Professor, Department of Ophthalmology, Rama Medical College Hospital and Research Centre, Hapur, Uttar Pradesh, India</aff>
<aff id="aff3"><label>3</label>Professor, Department of Ophthalmology, Rama Medical College Hospital and Research Centre, Hapur, Uttar Pradesh, India</aff>
<aff id="aff4"><label>4</label>Professor and Head of the Department, Department of Ophthalmology, Rama Medical College Hospital and Research Centre, Hapur, Uttar Pradesh, India</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><day>12</day><month>02</month><year>2026</year></pub-date>
<volume>7</volume>
<issue>1</issue>
<fpage>181</fpage>
<lpage>187</lpage>
<history>
<date date-type="received"><day>09</day><month>12</month><year>2025</year></date>
<date date-type="accepted"><day>10</day><month>01</month><year>2026</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/454/pterygium-excision-with-conjunctival-flap-transposition-and-intraoperative-mitomycin-c-adjunctive"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/454/download"/>
<abstract><p>Pterygium is a fibrovascular proliferative lesion of the bulbar conjunctiva that progressively invades the corneal surface, arising from a complex interplay of chronic ultraviolet radiation, oxidative stress, and limbal stem cell dysfunction, with pathophysiological mechanisms involving fibroblast activation, extracellular matrix remodeling, and angiogenesis that collectively account for the condition&apos;s well-documented tendency toward recurrence after surgical removal. The high postoperative recurrence rate associated with conventional bare-sclera excision, reported in some series to exceed 30 to 80 percent, has driven continued investigation into adjunctive strategies capable of modulating the wound-healing response at the surgical site. This prospective comparative clinical study was undertaken to evaluate the efficacy and safety of conjunctival flap transposition with simultaneous burial of the excised pterygium tissue performed either as a standalone procedure (Group 1, n=46) or in combination with intraoperative application of mitomycin C (Group 2, n=44) in patients presenting with primary nasal or temporal pterygium encroaching upon the cornea. A total of 90 eyes in 90 consecutive patients were enrolled from a single tertiary ophthalmology unit, randomized by allocation into the two groups, and followed for a minimum of six months with recurrence graded on a standardized four-grade scale. The primary findings demonstrated that Grade 0, or no recurrence, was observed in 69.6 percent of Group 1 patients and in 84.09 percent of Group 2 patients, indicating a clinically meaningful reduction in recurrence attributable to mitomycin C adjunction. Grade 3 true corneal recurrence occurred in 6.5 percent of Group 1 versus 2.27 percent of Group 2. While Group 2 demonstrated superior recurrence suppression, it was associated with a higher incidence of delayed wound healing (13.64%) and superficial punctate keratitis (13.64%), reflecting the known antiproliferative toxicity of mitomycin C on ocular surface epithelium. These findings support the cautious, judicious use of intraoperative mitomycin C as an adjunct to conjunctival flap transposition in appropriately selected patients, and underscore the need for further dose-optimization and long-term follow-up studies to refine its clinical application.</p></abstract>
<kwd-group kwd-group-type="author"><kwd>Pterygium</kwd><kwd>Mitomycin C</kwd><kwd>Conjunctival Flap Transposition</kwd><kwd>Recurrence</kwd><kwd>Ocular Surgery</kwd><kwd>Fibroblast Inhibition</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Duke-Elder S, Leigh AG. Diseases of the outer eye. In: Duke-Elder S, editor. System of ophthalmology. Vol. VIII, Part 1. London: Henry Kimpton; 1965. p. 573-85.</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Duke-Elder SS. Degenerative and pigmentary changes. In: Duke-Elder SS, editor. System of ophthalmology. 3rd ed. London: Henry Kimpton; 1979. p. 569-85.</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Srinivasan S, Slomovic AR. Eye rubbing causing conjunctival graft dehiscence following pterygium surgery with fibrin glue. Eye (Lond). 2007;21(6):865-7. doi:10.1038/sj.eye.6702320.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Miyai T, Hara R, Nejima R, Miyata K, Yonemura T, Amano S. Limbal allograft, amniotic membrane transplantation, and intraoperative mitomycin C for International Journal of Medical and All Body Health Research www.allmedicaljournal.com recurrent pterygium. Ophthalmology. 2005;112(7):1263-7. doi:10.1016/j.ophtha.2005.01.036.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Saw SM, Tan D. Pterygium: prevalence, demography and risk factors. Ophthalmic Epidemiol. 1999;6(3):219-28. doi:10.1076/opep.6.3.219.1504.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Bartlett RE, Mumma CS. Pterygia: etiologic theories, methods of treatment, and results. Calif Med. 1951;74(4):263-6.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 1985;92(11):1461-70. doi:10.1016/s0161-6420(85)33831-9.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Frucht-Pery J, Raiskup F, Ilsar M, Landau D, Orucov F, Solomon A. Intraoperative application of topical mitomycin C for pterygium surgery. Ophthalmology. 2006;113(3):401-7. doi:10.1016/j.ophtha.2005.11.020.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99(11):1647-54. doi:10.1016/s0161 -6420(92)31759-x.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Gris O, Güell JL, del Campo Z. Limbal-conjunctival autograft transplantation for the treatment of recurrent pterygium. Ophthalmology. 2000;107(2):270-3. doi:10.1016/s0161-6420(99)00097-3.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Malik KPS, Goel R, Gupta A, Bhattacharjee K, Bhattacharjee H. Efficacy of sutureless and glue-free conjunctival autograft for primary pterygium surgery. Nepal J Ophthalmol. 2012;4(1):4 -10. doi:10.3126/nepjoph.v4i1.6360.</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Janson BJ, Sikder S. Surgical management of pterygium. Ocul Surf. 2011;9(3):112-23. doi:10.1016/s1542-0124(11)70020-0.</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Kaufman SC, Jacobs DS, Lee WB, Deng SX, Rosenblatt MI, Shtein RM. Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology. Ophthalmology. 2013;120(1):201-8. doi:10.1016/j.ophtha.2012.08.007.</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Hirst LW. The treatment of pterygium. Surv Ophthalmol. 2003;48(2):145-80. doi:10.1016/s0039-6257(02)00463-0.</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Singh G, Wilson MR, Foster CS. Long-term follow-up study of mitomycin eye drops as adjunctive treatment of pterygia and its comparison with conjunctival autograft transplantation. Cornea. 1990;9(4):331 -4. doi:10.1097/00003226-199010000-00010.</mixed-citation></ref>
</ref-list></back>
</article>